Gapping down
In reaction to earnings/guidance:
- SMCI -9% (also names new CFO; announces new $200 mln stock repurchase program), TENB -7.2%, SPOT -7.1%, GSK -4.9%, MTCH -4.6%, HWM -4.2%, BIIB -3.8%, EA -3.5%, CMG -3%, AMGN -2.1%, BSX -2%, SANM -1.8%, ALB -1.5% (sees Q4 EPS and revs above consensus; also announces stock offering)
M&A news:
- JAZZ -4.7% (GW Pharma agrees to be acquired by Jazz Pharmaceuticals (JAZZ) for $220.00 per ADS in cash and shares)
Other news:
- VYGR -12.6% (VYGR and NBIX terminate Parkinson's disease portion of collaboration agreement)
- KRYS -6.7% (prices offering of 1,923,077 shares of its common stock at $65.00 per share)
- X -6.4% (upsizes offering by 2 mln shares and prices 42 mln shares of common stock at for gross proceeds of approximately $699 million)
- TMDI -5.3% (announces $15 mln bought deal offering)
- OPEN -4.9% (commences public offering of 24 mln shares)
- PBR -1% (reports Q4 production and sales)
- MKTX -0.9% (reports Jan volume statistics)
Analyst comments:
- HYLN -3.9% (downgraded to Sell from Neutral at Goldman
- RACE -2.6% (downgraded to Sell from Neutral at Citigroup)
- BYND -1.5% (downgraded to Underperform from Neutral at DA Davidson)
- CDEV -0.7% (downgraded to Underweight from Neutral at JP Morgan)